An interventional study of nano-eggshell varnish and Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)Dental Paste in Initial Dental Caries, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to participants aged 15 Years to 20 Years. Per ClinicalTrials.gov, last updated 2026-07-17.
Sponsored by Mansoura University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Dental Caries by Mansoura University — 5 open to participants now, 12 under way, none of them phase 3. Dental Caries · Mansoura University.
Among the 19 studies in Dental Caries by Mansoura University, this one is the 3rd largest by planned enrollment, is one of 6 that started in 2025, is one of 19 with no phase, reaches primary completion later than 6 of the 11 other live ones, and was the 15th registered.
1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →5 of the 19 studies in Dental Caries by Mansoura University are open now, in 1 country. Recruiting first, the newest first:
Mansoura University · Sites in Egypt
Ages 6–9
Mansoura University · Sites in Egypt
Ages 14–26
Mansoura University · Sites in Egypt
Ages 30–60 · Healthy volunteers
Mansoura University · Sites in Egypt
Ages 5–7 · Healthy volunteers
By country, each count listing its studies:
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 15 Years to 20 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 6 started in 2025.
This study's planned enrollment of 90 is above the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 40 across the 19 interventional studies. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Mansoura University is the lead sponsor of 1,121 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
6 of the studies in Dental Caries by Mansoura University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07711132Mansoura UniversityRemineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium Fluoride on Initial Enamel Caries | 2026-12-20 |
| NCT07052526Mansoura UniversityComparative Evaluation of Hydrophilic and Hydrophobic Sealants in Partially Erupted First Molars | 2027-01-01 |
| NCT06265116Mansoura UniversityOne-Step Universal Adhesives: A 3-year Clinical Trial in Class II Composite Restorations | 2027-01-23 |
| NCT07849478Mansoura UniversityTwo-year Clinical Performance of Ion-releasing and Conventional Bulk-fill Resin Composite Restorative Systems. | 2027-05 |
| NCT07849426Mansoura UniversityTwo Year Clinical Performance of Ion-releasing and Non Ion-releasing Composite Restorative Systems in Restoring Cervical Carious Lesions. | 2027-05 |
Add all 6 to your calendar (.ics) → With an account.
Among the 19 studies in Dental Caries by Mansoura University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled clinical trial aims to evaluate and compare the remineralizing effect of nano-eggshell varnish, CPP-ACP paste (GC Tooth Mousse), and sodium fluoride varnish on initial enamel caries among adolescents aged 15-20 years.
Participants will be randomly allocated into three groups. Remineralization and caries activity will be assessed using DIAGNOdent readings, International Caries Classification and Management System (ICCMS) criteria, and the decayed, missed, and filled surfaces (DMFS) index over a 12-month follow-up period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients' ages should be 15-20 years. Patients should have at least three to four teeth with ICDAS II scores of 1-2. Patients should have moderate-to-high caries risk.
Exclusion Criteria:
Known to one of the components of the material under study. Systemic disorders or medication interfering with normal salivary flow.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Nano-eggshell varnish will be professionally applied to the teeth surfaces every 3 months according to the manufacturer's instructions. Participants will be instructed to avoid eating or drinking for at least 30 minutes after application.
Drug: nano-eggshell varnish
Participants will be instructed to apply CPP-ACP (GC tooth mousse) daily after tooth brushing at bedtime. The material will be kept on the tooth surfaces for at least 3 minutes before rinsing.
Drug: Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)Dental Paste
Sodium fluoride varnish (5%) will be professionally applied every 3 months according to manufacturer instructions. Participants will be instructed to avoid eating or drinking for at least 30 minutes after application.
Drug: Sodium Fluoride Varnish (5%)
Nano-eggshell varnish is applied topically to tooth surfaces every 3 months, according to manufacturer instructions, to promote the remineralization of initial enamel caries.
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) paste was applied daily by participants after tooth brushing at bedtime and left on teeth for at least 3 minutes before rinsing.
5% sodium fluoride varnish is applied topically every 3 months according to manufacturer instructions as a controlled remineralizing agent.
Change in remineralization of initial enamel caries
Change in remineralization of initial enamel caries measured by DIAGNOdent readings from baseline to 12 months. When the DIAGNOdent reading decreases, it means good remineralization ability.
Time frame: Baseline to 12 months
Change in DIAGNOdent readings
The DIAGNOdent device will be used to quantify changes in enamel demineralization and remineralization over time. Measurements will be recorded at different follow-up intervals
Time frame: Baseline, 3, 6, 9, and 12 months
Caries activity assessment using ICCMS criteria
Caries activity will be assessed using the International Caries Classification and Management System (ICCMS) criteria. Lesions will be classified as active or inactive based on surface texture, appearance, and plaque stagnation area
Time frame: Baseline, 3, 6, 9, and 12 months
Change in the Decayed, Missing, and Filled Surfaces (DMFS) index
Dental caries experience will be evaluated using the Decayed, Missing, and Filled Surfaces (DMFS) index at baseline and after 6 and 12 months to assess overall changes in caries experience.
Time frame: baseline, after 6 and 12 months
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Data available upon request
Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 12 months after the start.
Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 12 months is below that.
Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Casein phosphopeptide-amorphous calcium phosphate nanocomplex